Replies to post #692980 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

LC,

Thanks for asking.

You’re reposting the same baseless innuendo and conjecture over and over. It sounds to me as if you’re attempting to defame certain individuals or spread rumors, but thanks for highlighting the period of time during which the leadership of the company built the prospective value of a pre-commercial biotech 😉

In my view, the most notable pre-commercial golden bricks that were carefully cemented into place as foundational supports beneath the company:

⭐️ Research Published in JAMA Oncology
⭐️ Research Published in Nature Communications
⭐️ Global Patent Portfolio
⭐️ Multiple MHRA Approvals
⭐️ Additional Emerging Combo Data
⭐️ Manufacturing Technology
⭐️ MAA Review

Further, Dr. Liau joining the SAB at Northwest Biotherapeutics is awesome!

Combo is King!

https://www.nature.com/articles/s41467-024-48073-y

https://www.jci.org/articles/view/169314

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-moves-from-optimization-of-flaskworks-prototype-to-fabrication-of-gmp-compliant-units-for-installation-validation-and-final-testing-prior-to-regulatory-certification-302054769.html

December 2023

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

September 2023

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-dr-linda-liau-has-joined-the-companys-scientific-advisory-board-301924864.html

March 2023

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license-for-commercial-manufacturing-at-sawston-uk-facility-301776725.html

December 2022

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility-301449083.html

August 2022

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-approval-of-pediatric-investigation-plan-pip-by-mhra-301610850.html

July 2022

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-filing-of-application-for-license-for-commercial-manufacturing-at-sawston-uk-facility-301581737.html

February 2022

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-commencement-of-cancer-vaccine-production-at-its-sawston-uk-facility-301484857.html

September 2020

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-acquires-flaskworks-301122058.html